GLP1R and obesity due to melanocortin 4 receptor deficiency: GLP-1 receptor agonists has been proven to be effective in weight loss, but for some diabetic patients, the degree of weight loss and anti-diabetic effects are not as good as bariatric surgery, in mainland China, GLP-1 receptor agonists has not yet received approval for treating obesity.